Thomas G. Wiggans - Dec 5, 2022 Form 4 Insider Report for PARDES BIOSCIENCES, INC. (PRDS)

Role
Chief Executive Officer, Director
Signature
/s/ Elizabeth Lacy, attorney-in-fact
Stock symbol
PRDS
Transactions as of
Dec 5, 2022
Transactions value $
$13,625
Form type
4
Date filed
12/7/2022, 03:29 PM
Previous filing
Dec 5, 2022
Next filing
Jan 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRDS Common Stock Purchase $13.6K +12.5K +33.33% $1.09 50K Dec 5, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in Column 4 is a weighted average price. The prices actually paid ranged from $1.02 to $1.20. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.